Search
Now showing items 1-2 of 2
The synthesis of an internal standard for bicalutamide
(University of the Free State, 2008-01)
English: (R,S)-Bicalutamide [N-(4-cyano-3-trifluoromethylphenyl)-α-methyl-α-hydroxy-β-(4-
fluorophenylsulfonyl)propanamide], sold as Casodex®, is the leading antiandrogen
currently used to treat prostate cancer. It binds ...
The synthesis of an internal standard for bicalutamide
(University of the Free State, 2008)
(R,S)-Bicalutamide [N-(4-cyano-3-trifluoromethylphenyl)-α-methyl-α-hydroxy-β-(4- fluorophenylsulfonyl)propanamide], sold as Casodex®, is the leading antiandrogen currently used to treat prostate cancer. It binds to androgen ...